Recent advances of imidazole-containing derivatives as anti-tubercular agents
YL Fan, XH Jin, ZP Huang, HF Yu, ZG Zeng… - European journal of …, 2018 - Elsevier
Tuberculosis still remains one of the most common, communicable, and leading deadliest
diseases known to mankind throughout the world. Drug-resistance in Mycobacterium …
diseases known to mankind throughout the world. Drug-resistance in Mycobacterium …
Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies
EA Abd El-Meguid, AM Naglah, GO Moustafa… - Bioorganic & Medicinal …, 2022 - Elsevier
A novel series of benzothiazole-based derivatives linked to various amino acids and their
corresponding ethyl ester analogues were prepared and were initially evaluated for their …
corresponding ethyl ester analogues were prepared and were initially evaluated for their …
Treating Hyperglycemia From Eryngium caeruleum M. Bieb: In-vitro α-Glucosidase, Antioxidant, in-vivo Antidiabetic and Molecular Docking-Based Approaches
Natural-based drugs are believed to be safe, effective and economical. Based on the
medicinal importance of the genus Eryngium and unexplored nature of Eryngium …
medicinal importance of the genus Eryngium and unexplored nature of Eryngium …
Tailoring the substitution pattern of Pyrrolidine-2, 5-dione for discovery of new structural template for dual COX/LOX inhibition
Dual inhibition of the enzymatic pathways of cyclooxygenases (COX-1/COX-2) and
lipoxygenase (LOX) is a rational approach for developing more efficient and safe anti …
lipoxygenase (LOX) is a rational approach for developing more efficient and safe anti …
Emerging target-directed approaches for the treatment and diagnosis of microbial infections
MC Almeida, PM da Costa, E Sousa… - Journal of Medicinal …, 2022 - ACS Publications
With the rising levels of drug resistance, developing efficient antimicrobial therapies has
become a priority. A promising strategy is the conjugation of antibiotics with relevant …
become a priority. A promising strategy is the conjugation of antibiotics with relevant …
Design and Synthesis of Imidazo/Benzimidazo[1,2-c]quinazoline Derivatives and Evaluation of Their Antimicrobial Activity
A new class of fused quinazolines has been designed and synthesized via copper-catalyzed
Ullmann type C–N coupling followed by intramolecular cross-dehydrogenative coupling …
Ullmann type C–N coupling followed by intramolecular cross-dehydrogenative coupling …
Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review
This article summarizes the most recent advancements in the synthetic and pharmacological
approaches along with the structure activity relationship towards the s-triazine and its …
approaches along with the structure activity relationship towards the s-triazine and its …
Synthesis and in vitro urease inhibitory activity of 5-nitrofuran-2-yl-thiadiazole linked to different cyclohexyl-2-(phenylamino) acetamides, in silico and kinetic studies
Abstract A series of 5-nitrofuran-2-yl-thiadiazole linked to different cyclohexyl-2-
(phenylamino) acetamides were rationally designed and synthesized. All synthetic …
(phenylamino) acetamides were rationally designed and synthesized. All synthetic …
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective
Nitroimidazoles based compounds remain a hot topic of research in medicinal chemistry
due to their numerous biological activities. Moreover, many clinical candidates based on this …
due to their numerous biological activities. Moreover, many clinical candidates based on this …
Exploring the ability of dihydropyrimidine-5-carboxamide and 5-benzyl-2, 4-diaminopyrimidine-based analogues for the selective inhibition of L. major Dihydrofolate …
M Bibi, NA Qureshi, A Sadiq, U Farooq… - European Journal of …, 2021 - Elsevier
To tackle leishmaniasis, search for efficient therapeutic drug targets should be pursued.
Dihydrofolate reductase (DHFR) is considered as a key target for the treatment of …
Dihydrofolate reductase (DHFR) is considered as a key target for the treatment of …